These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24614365)

  • 1. Targeted small interfering RNA-immunoliposomes as a promising therapeutic agent against highly pathogenic Avian Influenza A (H5N1) virus infection.
    Khantasup K; Kopermsub P; Chaichoun K; Dharakul T
    Antimicrob Agents Chemother; 2014 May; 58(5):2816-24. PubMed ID: 24614365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lyophilized HER2-specific PEGylated immunoliposomes for active siRNA gene silencing.
    Gao J; Sun J; Li H; Liu W; Zhang Y; Li B; Qian W; Wang H; Chen J; Guo Y
    Biomaterials; 2010 Mar; 31(9):2655-64. PubMed ID: 20035999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on the Antiviral Activities and Hemagglutinin-Based Molecular Mechanism of Novel Chlorogenin 3-
    Shi WZ; Jiang LZ; Song GP; Wang S; Xiong P; Ke CW
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32168921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monoclonal ScFv that bind to different functional domains of M2 and inhibit H5N1 influenza virus replication.
    Pissawong T; Maneewatch S; Thueng-In K; Srimanote P; Dong-din-on F; Thanongsaksrikul J; Songserm T; Tongtawe P; Bangphoomi K; Chaicumpa W
    Virol J; 2013 May; 10():148. PubMed ID: 23672256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. siRNAs targeting PB2 and NP genes potentially inhibit replication of Highly Pathogenic H5N1 Avian Influenza Virus.
    Behera P; Nagarajan S; Murugkar HV; Kalaiyarasu S; Prakash A; Gothalwal R; Dubey SC; Kulkarni DD; Tosh C
    J Biosci; 2015 Jun; 40(2):233-40. PubMed ID: 25963253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
    Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H
    Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
    Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of influenza virus siRNA expression vectors and their inhibitory effects on multiplication of influenza virus.
    Li YC; Kong LH; Cheng BZ; Li KS
    Avian Dis; 2005 Dec; 49(4):562-73. PubMed ID: 16405000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving siRNA design targeting nucleoprotein gene as antiviral against the Indonesian H5N1 virus.
    Hartawan R; Pujianto DA; Dharmayanti NLPI; Soebandrio A
    J Vet Sci; 2022 Mar; 23(2):e24. PubMed ID: 35187881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligonucleotide inhibits avian influenza virus H5N1 replication by single chain antibody delivery system.
    Zhang T; Zhao PS; Zhang W; Liang M; Gao YW; Yang ST; Wang TC; Qin C; Wang CY; Xia XZ
    Vaccine; 2011 Feb; 29(8):1558-64. PubMed ID: 21215341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligonucleotides targeting the RNA binding region of the NP gene inhibit replication of highly pathogenic avian influenza virus H5N1.
    Zhang T; Wang TC; Zhao PS; Liang M; Gao YW; Yang ST; Qin C; Wang CY; Xia XZ
    Int Immunopharmacol; 2011 Dec; 11(12):2057-61. PubMed ID: 21933722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference of avian influenza virus H5N1 by inhibiting viral mRNA with siRNA expression plasmids.
    Zhou K; He H; Wu Y; Duan M
    J Biotechnol; 2008 Jun; 135(2):140-4. PubMed ID: 18456361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery.
    Chen CW; Yeh MK; Shiau CY; Chiang CH; Lu DW
    Int J Nanomedicine; 2013; 8():2613-27. PubMed ID: 23901275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection.
    Cho J; Yi H; Jang EY; Lee MS; Lee JY; Kang C; Lee CH; Kim K
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):298-304. PubMed ID: 29017920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of specific single chain antibody variable fragment and siRNA has a synergistic inhibitory effect on the propagation of avian influenza virus H5N1 in chicken cells.
    Wang S; Zhang P; He F; Wang JG; Sun JZ; Li ZL; Yi B; Xi J; Mao YP; Hou Q; Yuan DL; Zhang ZD; Liu WQ
    Virol J; 2014 Nov; 11():208. PubMed ID: 25471220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host- and strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins.
    Bortz E; Westera L; Maamary J; Steel J; Albrecht RA; Manicassamy B; Chase G; Martínez-Sobrido L; Schwemmle M; García-Sastre A
    mBio; 2011; 2(4):. PubMed ID: 21846828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human single-chain antibodies that neutralize homologous and heterologous strains and clades of influenza A virus subtype H5N1.
    Maneewatch S; Thanongsaksrikul J; Songserm T; Thueng-In K; Kulkeaw K; Thathaisong U; Srimanote P; Tongtawe P; Tapchaisri P; Chaicumpa W
    Antivir Ther; 2009; 14(2):221-30. PubMed ID: 19430097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery.
    Zhang Y; Li H; Sun J; Gao J; Liu W; Li B; Guo Y; Chen J
    Int J Pharm; 2010 May; 390(2):198-207. PubMed ID: 20116418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and characterization of a fusion protein of single-chain fragment variable antibody against hemagglutinin antigen of avian influenza virus and truncated protamine.
    Zhang T; Wang CY; Zhang W; Gao YW; Yang ST; Wang TC; Zhang RZ; Qin C; Xia XZ
    Vaccine; 2010 May; 28(23):3949-55. PubMed ID: 20382243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.
    Kumaki Y; Day CW; Smee DF; Morrey JD; Barnard DL
    Antiviral Res; 2011 Nov; 92(2):329-40. PubMed ID: 21925541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.